PMS2 and Lynch syndrome: Among the 28 cases showing an MMR-d phenotype, 25 had a combined loss of MLH1 and PMS2 (including 19 SBAs with MLH1 methylation and 6 without MLH1 methylation, one of which was in a confirmed Lynch syndrome patient).